#25-27 Warrants issued by Diagonal Bio AB approved for listing at NGM

Report this content

Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in Diagonal Bio AB at NGM. The warrants of series TO2 issued by Diagonal Bio AB are also approved for listing, the first day of trading has been set to March 19, 2025.

 

Information regarding the affected instrument:

 

Listing name: Diagonal Bio TO2

Exchange symbol: DIABIO TO2

ISIN-code: SE0023615968

CFI-code: RSSXXR

FISN-code: DIAGONALBI/OPT RTS 20250618

Instrument-ID: H6QH

Tick size table/liquidity band: A

Number of issued warrants: 361 889 384

First day of trading: 2025-03-19

Last day of trading: 2025-06-16

Market-ID: NSME

Segment-ID: NSSE

 

For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se or telephone, +46 8 566 390 55.

 

NGM Market Notice Pressroom

https://news.cision.com/ngm-market-notice